• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测球状蛋白质中“易于聚集”肽的共识方法。

A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.

机构信息

Department of Cell Biology and Biophysics, Faculty of Biology, University of Athens, Panepistimiopolis, Athens, Greece.

出版信息

PLoS One. 2013;8(1):e54175. doi: 10.1371/journal.pone.0054175. Epub 2013 Jan 10.

DOI:10.1371/journal.pone.0054175
PMID:23326595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3542318/
Abstract

The purpose of this work was to construct a consensus prediction algorithm of 'aggregation-prone' peptides in globular proteins, combining existing tools. This allows comparison of the different algorithms and the production of more objective and accurate results. Eleven (11) individual methods are combined and produce AMYLPRED2, a publicly, freely available web tool to academic users (http://biophysics.biol.uoa.gr/AMYLPRED2), for the consensus prediction of amyloidogenic determinants/'aggregation-prone' peptides in proteins, from sequence alone. The performance of AMYLPRED2 indicates that it functions better than individual aggregation-prediction algorithms, as perhaps expected. AMYLPRED2 is a useful tool for identifying amyloid-forming regions in proteins that are associated with several conformational diseases, called amyloidoses, such as Altzheimer's, Parkinson's, prion diseases and type II diabetes. It may also be useful for understanding the properties of protein folding and misfolding and for helping to the control of protein aggregation/solubility in biotechnology (recombinant proteins forming bacterial inclusion bodies) and biotherapeutics (monoclonal antibodies and biopharmaceutical proteins).

摘要

这项工作的目的是构建一个组合现有的工具来预测球状蛋白中“易于聚集”肽的共识预测算法。这允许比较不同的算法,并产生更客观和准确的结果。将 11 种(11)个单独的方法进行组合,产生了 AMYLPRED2,这是一个可公开获取的免费学术网络工具(http://biophysics.biol.uoa.gr/AMYLPRED2),用于仅从序列预测蛋白质中的淀粉样决定簇/“易于聚集”肽的共识预测。AMYLPRED2 的性能表明,它的功能优于单个聚集预测算法,这可能是预期的。AMYLPRED2 是一种有用的工具,可用于识别与几种构象疾病(称为淀粉样变性)相关的蛋白质中的淀粉样形成区域,如阿尔茨海默病、帕金森病、朊病毒病和 2 型糖尿病。它也可能有助于了解蛋白质折叠和错误折叠的性质,并有助于控制生物技术(重组蛋白形成细菌包含体)和生物治疗学(单克隆抗体和生物制药蛋白)中的蛋白质聚集/溶解度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb63/3542318/f204d6a3e415/pone.0054175.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb63/3542318/f204d6a3e415/pone.0054175.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb63/3542318/f204d6a3e415/pone.0054175.g001.jpg

相似文献

1
A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.用于预测球状蛋白质中“易于聚集”肽的共识方法。
PLoS One. 2013;8(1):e54175. doi: 10.1371/journal.pone.0054175. Epub 2013 Jan 10.
2
Amyloidogenic determinants are usually not buried.淀粉样生成决定簇通常不被掩埋。
BMC Struct Biol. 2009 Jul 9;9:44. doi: 10.1186/1472-6807-9-44.
3
CPAD, Curated Protein Aggregation Database: A Repository of Manually Curated Experimental Data on Protein and Peptide Aggregation.CPAD,精心整理的蛋白质聚集数据库:一个关于蛋白质和肽聚集的手动整理实验数据的存储库。
PLoS One. 2016 Apr 4;11(4):e0152949. doi: 10.1371/journal.pone.0152949. eCollection 2016.
4
Fundamentals of cross-seeding of amyloid proteins: an introduction.淀粉样蛋白的共成核作用基础:引言。
J Mater Chem B. 2019 Dec 14;7(46):7267-7282. doi: 10.1039/c9tb01871a. Epub 2019 Oct 24.
5
Misfolding of amyloidogenic proteins and their interactions with membranes.淀粉样蛋白的错误折叠及其与膜的相互作用。
Biomolecules. 2013 Dec 27;4(1):20-55. doi: 10.3390/biom4010020.
6
Intrinsic aggregation propensity of the CsgB nucleator protein is crucial for curli fiber formation.CsgB成核蛋白的内在聚集倾向对卷曲纤维的形成至关重要。
J Struct Biol. 2016 Aug;195(2):179-189. doi: 10.1016/j.jsb.2016.05.012. Epub 2016 May 28.
7
Sequence and structure-based peptides as potent amyloid inhibitors: A review.基于序列和结构的肽作为有效的淀粉样抑制剂:综述。
Arch Biochem Biophys. 2020 Nov 30;695:108614. doi: 10.1016/j.abb.2020.108614. Epub 2020 Sep 30.
8
Evaluation of in silico tools for the prediction of protein and peptide aggregation on diverse datasets.评估不同数据集上用于预测蛋白质和肽聚集的计算工具。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab240.
9
Theoretical approaches to protein aggregation.蛋白质聚集的理论方法。
Protein Pept Lett. 2006;13(3):287-93. doi: 10.2174/092986606775338407.
10
The Amyloid Phenomenon and Its Links with Human Disease.淀粉样变现象及其与人类疾病的联系。
Cold Spring Harb Perspect Biol. 2017 Jun 1;9(6):a023648. doi: 10.1101/cshperspect.a023648.

引用本文的文献

1
Structural polymorphism of ALECT2 amyloid fibrils revealed by cryo-EM.冷冻电镜揭示的 ALECT2 淀粉样纤维的结构多态性
bioRxiv. 2025 Jul 18:2025.07.15.664973. doi: 10.1101/2025.07.15.664973.
2
Amyloid fibrils of the myelin basic protein are an integral component of myelin in the vertebrate brain.髓鞘碱性蛋白的淀粉样原纤维是脊椎动物大脑中髓鞘的一个组成部分。
Sci Rep. 2025 Aug 8;15(1):29053. doi: 10.1038/s41598-025-13524-z.
3
Non-native entanglement protein misfolding observed in all-atom simulations and supported by experimental structural ensembles.

本文引用的文献

1
The amyloid state of proteins in human diseases.蛋白质在人类疾病中的淀粉样状态。
Cell. 2012 Mar 16;148(6):1188-203. doi: 10.1016/j.cell.2012.02.022.
2
Exploiting heterogeneous features to improve in silico prediction of peptide status - amyloidogenic or non-amyloidogenic.挖掘异质特征以提高肽状态(淀粉样变性或非淀粉样变性)的计算预测。
BMC Bioinformatics. 2011;12 Suppl 13(Suppl 13):S21. doi: 10.1186/1471-2105-12-S13-S21. Epub 2011 Nov 30.
3
The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.
在全原子模拟中观察到并得到实验结构集合支持的非天然缠结蛋白错误折叠。
Sci Adv. 2025 Aug 8;11(32):eadt8974. doi: 10.1126/sciadv.adt8974.
4
Cryo-EM of cardiac AL-224L amyloid reveals shared features in λ6 light chain fibril folds.心脏AL-224L淀粉样蛋白的冷冻电镜揭示了λ6轻链原纤维折叠的共同特征。
bioRxiv. 2025 Jul 1:2025.06.25.661559. doi: 10.1101/2025.06.25.661559.
5
Amyloid-forming property of the N-terminal 1-70 residues of human apolipoprotein A-IV.人载脂蛋白A-IV N端1-70个残基的淀粉样蛋白形成特性。
Sci Rep. 2025 Apr 16;15(1):13203. doi: 10.1038/s41598-025-97992-3.
6
Generating the polymorph landscapes of amyloid fibrils using AI: RibbonFold.利用人工智能生成淀粉样纤维的多晶型景观:RibbonFold。
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2501321122. doi: 10.1073/pnas.2501321122. Epub 2025 Apr 15.
7
An unusual phenotype of hereditary AApoAI amyloidosis caused by a novel Asp20Tyr substitution is linked to pH-dependent aggregation of apolipoprotein A-I.由新型Asp20Tyr替代引起的遗传性载脂蛋白AI淀粉样变性的一种不寻常表型与载脂蛋白A-I的pH依赖性聚集有关。
Biochim Biophys Acta Mol Basis Dis. 2025 Jun;1871(5):167820. doi: 10.1016/j.bbadis.2025.167820. Epub 2025 Mar 29.
8
A cysteine-less and ultra-fast split intein rationally engineered from being aggregation-prone to highly efficient in protein trans-splicing.一种经过合理设计的无半胱氨酸且超快的分裂内含肽,从易于聚集转变为在蛋白质反式剪接中具有高效性。
Nat Commun. 2025 Mar 19;16(1):2723. doi: 10.1038/s41467-025-57596-x.
9
Prion-like Properties of Short Isoforms of Human Chromatin Modifier PHC3.人类染色质修饰因子PHC3短异构体的类朊病毒特性
Int J Mol Sci. 2025 Feb 11;26(4):1512. doi: 10.3390/ijms26041512.
10
Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stage.膀胱癌中的淀粉样蛋白会劫持与癌症相关的蛋白质,并且与肿瘤分期呈正相关。
Sci Rep. 2025 Feb 5;15(1):4393. doi: 10.1038/s41598-025-88307-7.
转甲状腺素淀粉样变性:从阐明与病理学相关的聚集分子机制到获得监管机构批准的药物。
J Mol Biol. 2012 Aug 10;421(2-3):185-203. doi: 10.1016/j.jmb.2011.12.060. Epub 2012 Jan 5.
4
Aggregation, immune complexes and immunogenicity.聚集、免疫复合物和免疫原性。
MAbs. 2011 Nov-Dec;3(6):503-4. doi: 10.4161/mabs.3.6.17611. Epub 2011 Nov 1.
5
Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone regions.基于蛋白质的生物治疗药物聚集:识别易聚集区域的计算研究和工具。
J Pharm Sci. 2011 Dec;100(12):5081-95. doi: 10.1002/jps.22705. Epub 2011 Jul 24.
6
A method for probing the mutational landscape of amyloid structure.一种探测淀粉样结构突变特征的方法。
Bioinformatics. 2011 Jul 1;27(13):i34-42. doi: 10.1093/bioinformatics/btr238.
7
Biological role of bacterial inclusion bodies: a model for amyloid aggregation.细菌包含体的生物学作用:淀粉样蛋白聚集的模型。
FEBS J. 2011 Jul;278(14):2419-27. doi: 10.1111/j.1742-4658.2011.08165.x. Epub 2011 May 31.
8
Protein aggregation and amyloid fibril formation prediction software from primary sequence: towards controlling the formation of bacterial inclusion bodies.从一级序列预测蛋白质聚集和淀粉样纤维形成的软件:控制细菌包含体形成。
FEBS J. 2011 Jul;278(14):2428-35. doi: 10.1111/j.1742-4658.2011.08164.x. Epub 2011 May 31.
9
Coupling of aggregation and immunogenicity in biotherapeutics: T- and B-cell immune epitopes may contain aggregation-prone regions.生物疗法中聚集和免疫原性的偶联:T 细胞和 B 细胞免疫表位可能含有易于聚集的区域。
Pharm Res. 2011 May;28(5):949-61. doi: 10.1007/s11095-011-0414-9. Epub 2011 Mar 25.
10
Protein aggregation from inclusion bodies to amyloid and biomaterials.蛋白质从包涵体到淀粉样纤维和生物材料的聚集。
Adv Protein Chem Struct Biol. 2010;79:89-125. doi: 10.1016/S1876-1623(10)79003-9.